Value | Compounding Profile picture
Value investing | Tweets are only for educational purpose | No Recommendations | Don't follow me for stock advice
Oct 10, 2022 7 tweets 2 min read
A thread on my mistakes in stock market so far. 🧵

I know many times I have boasted myself for doing well in stock market. Now let me share my blunders as well. 1. Buying debt-ridden & loss-making businesses in anticipation of turnaround:

I bought Punj Lloyd and Lanco Infra (in 2013 & 2014) at lower levels as I was greedy to earn more returns. I still hold both of them as I can remember that I won’t have to do it again.
May 11, 2021 6 tweets 2 min read
A thread on #Mucormycosis :

One of the lethal complications of Covid is Mucormycosis, also known as ‘Black fungus’ #infection. This dangerous fungal infection affects the nose, eye and sometimes the brain. My colleagues in ENT and Ophthalmology told me that previously (1/n) ...this disease was rare and they used to get only 1-2 cases per year but now they are getting 2-3 cases/day.Diabetics are more prone to suffer from this disease as high sugar levels are favourable for mucor’s growth. Excess use of steroids in Covid also increases...(2/n)
Jan 6, 2021 14 tweets 3 min read
Investors’ 8 most common behavioral biases:
~Confirmation Bias
~Optimism Bias
~Loss Aversion
~Self-Serving Bias
~The Planning Fallacy
~Choice Paralysis
~Herding
~Recency Bias
#BehavioralFinance ~Confirmation Bias: Confirmation bias is the tendency to process information by looking for, or interpreting, information that is consistent with investor’s existing beliefs. E.g. An investor thinks that one can buy growth stocks at any prices so he searches articles of.....
Sep 22, 2020 8 tweets 2 min read
API product portfolio of RPG life sciences:
Azathioprine
Haloperidol & Haloperidol decanoate
Diphenoxylate hydrochloride
Mycophenolate Mofetyl Mycophenolate Na
Lamotrigine
Nicorandil
Tolvaptan
Spironolactone
Sertraline
Risperidone
Quinfamine
Propantheline Br
Pentoprazole Na Sesq RPG's FORMULATION R&D HAS MADE KEY BREAKTHROUGH ACHIEVEMENTS:

1. Cyclosporine micro-emulsion Novel Drug Delivery System granted patent in about 20 countries including US and European countries

2. Lamotrigine Mouth Dissolving tablets patented internationally and India (1/3)
Aug 13, 2020 18 tweets 4 min read
A thread: Acquisitions, mergers and demergers of Pharmaceuticals and Chemicals MNCs:
Ciba-Geigy AG, was a swiss pharmaceutical giant formed in 1970 from the merger of Ciba AG and J.R. Geigy SA. Ciba started out in the 1850s as a silk-dyeing business and branched out into pharma. In 1996, the pharmaceutical business of Sandoz was merged with Ciba-Geigy to form Novartis and chemicals business of Sandoz was hived off to a different company named Clariant chemicals. Later, in December 1999 , the spin-off and merger of the agrochemical and seed division of...
May 8, 2020 7 tweets 1 min read
Abolishment of dividend distribution tax will encourage more MNCs to give hefty dividends. In this financial year few companies have already declared hefty dividends which are as follows:
1. Pfizer:320 rs./share
2. SKF India:130 rs./shr
3. Oracle fin. services:180 rs./shr
(1/2) Sanofi has announced a dividend of 352 rs./shr in last financial year but record date is yet to be declared.
All cash rich MNCs are future candidates for hefty dividends.
Discl: Not a buying recommendation.